Log In
BCIQ
Print this Print this
 

LP226A1

  Manage Alerts
Collapse Summary General Information
Company Lipopharma Therapeutics S.L.
DescriptionSynthetic derivative of docosahexaenoic acid (DHA)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today